Versant Ventures

San Francisco, United States · Pure DeepTech
Out of Scope

Bio

Versant Ventures Versant Ventures was founded in 1999 and manages $5.3B in AUM, making it one of the most successful life sciences VCs globally. The most recent raise totaled $950M across three vehicles. $560M for company formation, $140M for co-investment, and $250M for growth. The portfolio spans 190 companies with 95+ acquisitions and IPOs. What distinguishes Versant is its "Discovery Engines". in-house scientist teams operating in state-of-the- art lab facilities to create companies from s

Industries

BiotechMedTech

Stages

SeedSeries A

Geography

USEurope

Notable investments

  • Audentes Therapeutics
  • Crinetics Pharmaceuticals
  • Atreca